Relevant bibliographies by topics / Bone morphogenetic proteins / Journal articles

Journal articles on the topic 'Bone morphogenetic proteins'

To see the other types of publications on this topic, follow the link: Bone morphogenetic proteins.
Author: Grafiati
Published: 4 June 2021
Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Bone morphogenetic proteins.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sharma, Anamika, and Himani Sharma. "Bone Morphogenetic Proteins: An Overview." Annals of Applied Bio-Sciences 4, no. 2 (April 10, 2017): R35—R37. http://dx.doi.org/10.21276/aabs.1336.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Einhorn, Thomas A. "BONE MORPHOGENETIC PROTEINS." Journal of Bone & Joint Surgery 79, no. 2 (February 1997): 318. http://dx.doi.org/10.2106/00004623-199702000-00024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Einhorn, Thomas A. "Bone Morphogenetic Proteins." Journal of Bone and Joint Surgery (American Volume) 79, no. 2 (February 1997): 319. http://dx.doi.org/10.2106/00004623-199702000-00026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

TERMAAT, M. F., F. C. DEN BOER, F. C. BAKKER, P. PATKA, and H. J. TH M. HAARMAN. "BONE MORPHOGENETIC PROTEINS." Journal of Bone and Joint Surgery-American Volume 87, no. 6 (June 2005): 1367–78. http://dx.doi.org/10.2106/00004623-200506000-00027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Katagiri, Takenobu, and Tetsuro Watabe. "Bone Morphogenetic Proteins." Cold Spring Harbor Perspectives in Biology 8, no. 6 (June 2016): a021899. http://dx.doi.org/10.1101/cshperspect.a021899.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

&NA;. "Bone Morphogenetic Proteins." Back Letter 25, no. 11 (November 2010): 125–26. http://dx.doi.org/10.1097/01.back.0000390600.95274.20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chen, Di, Ming Zhao, and Gregory R. Mundy. "Bone Morphogenetic Proteins." Growth Factors 22, no. 4 (December 2004): 233–41. http://dx.doi.org/10.1080/08977190412331279890.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Carreira, A. C., F. H. Lojudice, E. Halcsik, R. D. Navarro, M. C. Sogayar, and J. M. Granjeiro. "Bone Morphogenetic Proteins." Journal of Dental Research 93, no. 4 (January 3, 2014): 335–45. http://dx.doi.org/10.1177/0022034513518561.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wozney, John M. "Bone Morphogenetic Proteins." Progress in Growth Factor Research 1, no. 4 (January 1989): 267–80. http://dx.doi.org/10.1016/0955-2235(89)90015-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Azari, Kodi, John S. Doctor, Bruce A. Doll, and Jeffrey O. Hollinger. "Bone morphogenetic proteins." Oral and Maxillofacial Surgery Clinics of North America 14, no. 1 (February 2002): 1–14. http://dx.doi.org/10.1016/s1042-3699(02)00011-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Bibbo, Christopher, Jonas Nelson, David Ehrlich, and Brian Rougeux. "Bone Morphogenetic Proteins." Clinics in Podiatric Medicine and Surgery 32, no. 1 (January 2015): 35–43. http://dx.doi.org/10.1016/j.cpm.2014.09.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Towler, Dwight A. "Bone morphogenetic proteins." Blood 114, no. 10 (September 3, 2009): 2012–13. http://dx.doi.org/10.1182/blood-2009-06-228544.

Full text
Abstract:
Abstract BMP2 and BMP4 play crucial inductive roles during development. In this issue of Blood, Shao et al demonstrate that an intricate network of paracrine BMP2/4 signals also regulates angiogenesis—and will very likely interact with endocrine BMP cues during wound repair.1
APA, Harvard, Vancouver, ISO, and other styles
13

Reddi, Hari. "Bone Morphogenetic Proteins." Advances in Dental Research 9, no. 3_suppl (November 1995): 13. http://dx.doi.org/10.1177/0895937495009003s0401.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Aihanuwa, Uwagie-Ero, Kene Chukwujekwu, and Chilaka Chukwuemeke. "Bone Morphogenetic Proteins an Update and Review." Tropical Journal of Natural Product Reseach 1, no. 1 (July 14, 2017): 1–11. http://dx.doi.org/10.26538/tjnpr/v1i1.2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Reddi, A. H. "BMPs: From bone morphogenetic proteins to body morphogenetic proteins." Cytokine & Growth Factor Reviews 16, no. 3 (June 2005): 249–50. http://dx.doi.org/10.1016/j.cytogfr.2005.04.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Malysheva, Kh V., I. M. Spasyuk, O. K. Pavlenko, R. S. Stoika, and O. G. Korchynsky. "Generation of optimized preparations of bone morphogenetic proteins for bone regeneration." Ukrainian Biochemical Journal 88, no. 6 (December 14, 2016): 87–97. http://dx.doi.org/10.15407/ubj88.06.087.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Ripamonti, Ugo, and Nicolaas Duneas. "Tissue Morphogenesis and Regeneration by Bone Morphogenetic Proteins." Plastic and Reconstructive Surgery 101, no. 1 (January 1998): 227–39. http://dx.doi.org/10.1097/00006534-199801000-00040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Yoshikawa, Hideki, Takanobu Nakase, Akira Myoui, and Takafumi Ueda. "Bone morphogenetic proteins in bone tumors." Journal of Orthopaedic Science 9, no. 3 (May 2004): 334–40. http://dx.doi.org/10.1007/s00776-004-0764-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Mussano, Federico, Giovannino Ciccone, Manuela Ceccarelli, Ileana Baldi, and Francesco Bassi. "Bone Morphogenetic Proteins and Bone Defects." Spine 32, no. 7 (April 2007): 824–30. http://dx.doi.org/10.1097/01.brs.0000259227.51180.ca.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Rengachary, Setti S. "Bone morphogenetic proteins: basic concepts." Neurosurgical Focus 13, no. 6 (December 2002): 1–6. http://dx.doi.org/10.3171/foc.2002.13.6.3.

Full text
Abstract:
The cellular and molecular events governing bone formation in the embryo, healing of a fractured bone, and induced bone fusion follow a similar pattern. Discovery, purification, and recombinant synthesis of bone morphogenetic proteins (BMPs) constiute a major milestone in the understanding of bone physiology. In this review the author discusses the mechanism of action, clinical applications, dosage, and optimum carriers for BMPs. The roles played by other growth factors are also discussed.
APA, Harvard, Vancouver, ISO, and other styles
21

Rao, SubramaniamM, GauriM Ugale, and ShivarajB Warad. "Bone morphogenetic proteins: Periodontal regeneration." North American Journal of Medical Sciences 5, no. 3 (2013): 161. http://dx.doi.org/10.4103/1947-2714.109175.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Hwang, Chang Ju, Alexander R. Vaccaro, James P. Lawrence, Joseph Hong, Huub Schellekens, Moulay Hicham Alaoui-Ismaili, and Dean Falb. "Immunogenicity of bone morphogenetic proteins." Journal of Neurosurgery: Spine 10, no. 5 (May 2009): 443–51. http://dx.doi.org/10.3171/2009.1.spine08473.

Full text
Abstract:
Object The object of this paper is to review the immunogenicity of bone morphogenetic proteins (BMPs) and to compare the results of the immunogenicity characterization and clinical consequences between recombinant human (rh)BMP-2 and recombinant human osteogenic protein-1 (rhOP-1/BMP-7). Methods The immunogenicity of therapeutic proteins and its clinical effects were reviewed. The characteristics of BMPs were also described in terms of immunogenicity. The methods and results of antibody detection in various clinical trials of rhBMP-2 and rhOP-1 were compared, including the most recent studies using a systematic characterization strategy with both a binding assay and bioassay. Results Similar to all recombinant human proteins, rhBMPs induce immune responses in a select subgroup of patients. Adverse effects from this response in these patients, however, have not been reported with antibody formation to either rhBMP-2 or rhOP-1. Overall, the incidence of antibody formation was slightly higher in rhOP-1 trials than in rhBMP-2 trials. Conclusions Although they occur in a subgroup of patients, the immune responses against rhBMPs have no correlation with any clinical outcome or safety parameter. Clinicians, however, must be aware of the potential complications caused by the immunogenicity of BMPs until more studies clearly elucidate their safety.
APA, Harvard, Vancouver, ISO, and other styles
23

Sharma, Himani, and Anamika Sharma. "Bone morphogenetic proteins: Revivifying periodontium." Indian Journal of Multidisciplinary Dentistry 9, no. 1 (2019): 58. http://dx.doi.org/10.4103/ijmd.ijmd_21_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Thawani, Jayesh P., Anthony C. Wang, Khoi D. Than, Chia-Ying Lin, Frank La Marca, and Paul Park. "Bone Morphogenetic Proteins and Cancer." Neurosurgery 66, no. 2 (February 1, 2010): 233–46. http://dx.doi.org/10.1227/01.neu.0000363722.42097.c2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Wozney, John M. "Overview of Bone Morphogenetic Proteins." Spine 27, Supplement (August 2002): S2—S8. http://dx.doi.org/10.1097/00007632-200208151-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Helm, Greg, D. Greg Anderson, Gunnar B. J. Andersson, Scott D. Boden, Christopher Damien, Sohei Ebara, Joseph M. Lane, et al. "Summary Statement: Bone Morphogenetic Proteins." Spine 27, Supplement (August 2002): S9. http://dx.doi.org/10.1097/00007632-200208151-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Huylebroeck, Danny. "Bone morphogenetic proteins go endothelial." Blood 109, no. 5 (March 1, 2007): 1794–95. http://dx.doi.org/10.1182/blood-2006-12-061994.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Hogan, Brigid LM. "Bone morphogenetic proteins in development." Current Opinion in Genetics & Development 6, no. 4 (August 1996): 432–38. http://dx.doi.org/10.1016/s0959-437x(96)80064-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Prakash, C. A., J. Parthiban, R. Balakrishnan, B. Anandh, and B. Lokesh. "Bone Morphogenetic Proteins-An Update." Biomedical and Pharmacology Journal 8, october Spl Edition (October 22, 2015): 329–33. http://dx.doi.org/10.13005/bpj/699.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Bramlage, C. P., T. Häupl, C. Kaps, P. Bramlage, G. A. Müller, and F. Strutz. "Bone Morphogenetic Proteins im Skelettsystem—." Zeitschrift für Rheumatologie 64, no. 6 (September 2005): 416–22. http://dx.doi.org/10.1007/s00393-005-0665-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Mukhametov, Ural F., Sergey V. Lyulin, Dmitry Yu Borzunov, and Ilgiz F. Gareev. "Methods for assessing the effectiveness of using bone morphogenetic proteins in spondylodesis." HERALD of North-Western State Medical University named after I.I. Mechnikov 14, no. 3 (November 16, 2022): 13–25. http://dx.doi.org/10.17816/mechnikov106089.

Full text
Abstract:
BACKGROUND: Today, growth factors, in particular bone morphogenetic proteins in the composition of osteoplastic materials, are widely used to accelerate bone tissue regeneration after injuries or diseases of the musculoskeletal system. There are various methods for evaluating the effectiveness of using these proteins, in particular, the methods for medical imaging and determining specific markers. Bone loss often occurs after trauma or injury, including surgery. Rapid impairment of bone formation and increased bone resorption, as reflected by biochemical markers of bone metabolism, may cause this bone loss. Therefore, the detection of these markers in patients after spinal fusion using bone morphogenetic proteins is important in assessing the effectiveness of this therapy at various stages of observation in the postoperative period. However, due to the widespread use of bone morphogenetic proteins, their therapeutic efficacy can increasingly be seen in everyday radiological practice. X-ray or computed tomography is usually used to assess the effectiveness of the surgical intervention. Magnetic resonance imaging may be a useful adjunct, however, postoperative magnetic resonance imaging analysis is vulnerable to hardware artifacts. Although there is extensive data in the literature on the outcomes of surgical interventions for spondylodesis using bone morphogenetic proteins, radiographic data and data on the detection of specific markers and their use are scarce. AIM: In this study, we will discuss the current knowledge about existing and possible methods for evaluating the effectiveness of the use of bone morphogenetic proteins in spondylodesis. MATERIALS AND METHODS: Using PubMed, Embase, the Cochrane Database, and Google Scholar, we conducted a comprehensive literature search demonstrating possible methods for evaluating the effectiveness of bone morphogenetic proteins in spondylodesis. RESULTS: This study presents various methods for determining the effectiveness of the use of bone morphogenetic proteins in spondylodesis. In addition, the results of preclinical and clinical studies, which analyzed the effectiveness of the use of bone morphogenetic proteins, have been analyzed. CONCLUSIONS: To identify the effectiveness of bone morphogenetic proteins in spondylodesis further preclinical and clinical studies are required.
APA, Harvard, Vancouver, ISO, and other styles
32

Ripamonti, Ugo, and A. Hari Reddi. "Tissue Engineering, Morphogenesis, and Regeneration of the Periodontal Tissues By Bone Morphogenetic Proteins." Critical Reviews in Oral Biology & Medicine 8, no. 2 (April 1997): 154–63. http://dx.doi.org/10.1177/10454411970080020401.

Full text
Abstract:
Tissue engineering is the emerging field of science developing techniques for fabrication of new tissues for replacement based on principles of cell and developmental biology and biomaterials. Morphogenesis is the cascade of pattern formation and the attainment of form of the various organs and the organism as a whole. The periodontium consists of the periodontal ligament, cementum, and alveolar bone. Bone has considerable potential for regeneration and therefore is a prototypic model for tissue engineering. The three main ingredients for tissue engineering are regulatory signals, responding stem cells, and extracellular matrix. Recent advances in molecular biology of the bone morphogenetic proteins (BMPs) have set the stage for tissue engineering of bone and related tissues, including the periodontium. Bone-derived BMPs, with a collagenous matrix as carrier, induced cementum and alveolar bone regeneration in surgically created furcation defects in the primate. It is noteworthy that there was morphogenesis of periodontal ligament and a faithful insertion of Sharpey's fibers into cementum. In the same furcation model, recombinant human osteogenic protein-1 (rhOP-1, also known as BMP-7), in conjunction with the collagenous carrier, induced extensive cementogenesis with insertion of Sharpey's fibers into the newly formed cementum. The observation that BMPs induce cementogenesis and periodontal ligament formation indicates that these proteins may have multiple functions in vivo not limited to cartilage and bone induction. The rapid advances in the molecular biology of BMPs and their receptors bode well for novel strategies to engineer the regeneration of the periodontal tissues.
APA, Harvard, Vancouver, ISO, and other styles
33

Walker, David H., and Neill M. Wright. "Bone morphogenetic proteins and spinal fusion." Neurosurgical Focus 13, no. 6 (December 2002): 1–13. http://dx.doi.org/10.3171/foc.2002.13.6.4.

Full text
Abstract:
Bone morphogenetic proteins (BMPs) have increasingly become a focus of research in the laboratory, with animal models, and in human clinical trials for the treatment of spinal disorders. Basic science research has elucidated the putative mechanism of action of BMPs, and the efficacy of BMPs in inducing bone formation has been evaluated in multiple animal models of anterior and posterior spinal fusion. Not only has BMP been shown to improve the quality and amount of bone formation when used as a supplement to autograft, it has also been shown to promote superior fusion in the absence of autograft, even in high-risk fusion models involving the use of nicotine or nonsteroidal antiinflam-matory agents. Both completed and ongoing clinical trials have demonstrated the efficacy of recombinant BMP, leading to the first BMP product being approved for clinical use earlier this year. Animal models and clinical trials have also been used to evaluate the safety of BMPs. Although few complications have been reported, BMPs can induce heterotopic bone formation, especially when placed adjacent to exposed neural elements. Potentially more serious, antibody formation has been seen in up to 38% of patients in some clinical trials. No clinical sequelae have been reported despite the development of antibodies against BMP, a naturally occurring human protein implicated in processes other than osteoinduction. The future directions of biological manipulation of the osteoinduction process include further understanding of the interactions of the BMP subtypes, the interactions of BMP with its receptors, and exploring other molecules capable of osteoinduction.
APA, Harvard, Vancouver, ISO, and other styles
34

Elmasry, Khaled, Samar Habib, Mohamed Moustafa, and Mohamed Al-Shabrawey. "Bone Morphogenetic Proteins and Diabetic Retinopathy." Biomolecules 11, no. 4 (April 18, 2021): 593. http://dx.doi.org/10.3390/biom11040593.

Full text
Abstract:
Bone morphogenetic proteins (BMPs) play an important role in bone formation and repair. Recent studies underscored their essential role in the normal development of several organs and vascular homeostasis in health and diseases. Elevated levels of BMPs have been linked to the development of cardiovascular complications of diabetes mellitus. However, their particular role in the pathogenesis of microvascular dysfunction associated with diabetic retinopathy (DR) is still under-investigated. Accumulated evidence from our and others’ studies suggests the involvement of BMP signaling in retinal inflammation, hyperpermeability and pathological neovascularization in DR and age-related macular degeneration (AMD). Therefore, targeting BMP signaling in diabetes is proposed as a potential therapeutic strategy to halt the development of microvascular dysfunction in retinal diseases, particularly in DR. The goal of this review article is to discuss the biological functions of BMPs, their underlying mechanisms and their potential role in the pathogenesis of DR in particular.
APA, Harvard, Vancouver, ISO, and other styles
35

Jain, AenaPundir, Siddharth Pundir, and Anamika Sharma. "Bone morphogenetic proteins: The anomalous molecules." Journal of Indian Society of Periodontology 17, no. 5 (2013): 583. http://dx.doi.org/10.4103/0972-124x.119275.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Ducy, Patricia, and Gerard Karsenty. "The family of bone morphogenetic proteins." Kidney International 57, no. 6 (June 2000): 2207–14. http://dx.doi.org/10.1046/j.1523-1755.2000.00081.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Singh, Kern, Dustin H. Massel, Benjamin C. Mayo, Daniel D. Bohl, William W. Long, and Krishna D. Modi. "Bone Morphogenetic Proteins in Lumbar Arthrodesis." Journal of Bone and Joint Surgery 98, no. 13 (July 2016): e57. http://dx.doi.org/10.2106/jbjs.16.00316.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Malham, Gregory M., Graham G. Giles, Roger L. Milne, Carl M. Blecher, and Graeme A. Brazenor. "Bone Morphogenetic Proteins in Spinal Surgery." Spine 40, no. 22 (November 2015): 1737–42. http://dx.doi.org/10.1097/brs.0000000000001184.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Azari, Kodi, Bruce A. Doll, Charles Sfeir, Ying Mu, and Jeffrey O. Hollinger. "Therapeutic potential of bone morphogenetic proteins." Expert Opinion on Investigational Drugs 10, no. 9 (September 2001): 1677–86. http://dx.doi.org/10.1517/13543784.10.9.1677.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Felin, Jenny E., Jaime L. Mayo, Trina J. Loos, J. Daniel Jensen, Daniel K. Sperry, Stephanie L. Gaufin, Christopher A. Meinhart, Jennie B. Moss, and Laura C. Bridgewater. "Nuclear variants of bone morphogenetic proteins." BMC Cell Biology 11, no. 1 (2010): 20. http://dx.doi.org/10.1186/1471-2121-11-20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Nauth, Aaron, Peter V. Giannoudis, Thomas A. Einhorn, Kurt D. Hankenson, Gary E. Friedlaender, Ru Li, and Emil H. Schemitsch. "Growth Factors: Beyond Bone Morphogenetic Proteins." Journal of Orthopaedic Trauma 24, no. 9 (September 2010): 543–46. http://dx.doi.org/10.1097/bot.0b013e3181ec4833.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Gautschi, Oliver P., Sönke P. Frey, and René Zellweger. "BONE MORPHOGENETIC PROTEINS IN CLINICAL APPLICATIONS." ANZ Journal of Surgery 77, no. 8 (August 2007): 626–31. http://dx.doi.org/10.1111/j.1445-2197.2007.04175.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Aspenberg, P., and C. Forslund. "Bone morphogenetic proteins and tendon repair." Scandinavian Journal of Medicine & Science in Sports 10, no. 6 (December 2000): 372–75. http://dx.doi.org/10.1034/j.1600-0838.2000.010006372.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Carlisle, Elliot, and Jeffrey S. Fischgrund. "Bone morphogenetic proteins for spinal fusion." Spine Journal 5, no. 6 (November 2005): S240—S249. http://dx.doi.org/10.1016/j.spinee.2005.02.014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Hruska, Keith A., Suresh Mathew, and Georges Saab. "Bone Morphogenetic Proteins in Vascular Calcification." Circulation Research 97, no. 2 (July 22, 2005): 105–14. http://dx.doi.org/10.1161/01.res.00000175571.53833.6c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Winn, Shelley R., Hasan Uludag, and Jeffrey O. Hollinger. "Carrier Systems for Bone Morphogenetic Proteins." Clinical Orthopaedics and Related Research 367 (October 1999): S95—S106. http://dx.doi.org/10.1097/00003086-199910001-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

van der Kraan, P. M., E. N. Blaney Davidson, and W. B. van den Berg. "Bone Morphogenetic Proteins and articular cartilage." Osteoarthritis and Cartilage 18, no. 6 (June 2010): 735–41. http://dx.doi.org/10.1016/j.joca.2010.03.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Giannoudis, Peter V., and Thomas A. Einhorn. "Bone morphogenetic proteins in musculoskeletal medicine." Injury 40 (December 2009): S1—S3. http://dx.doi.org/10.1016/s0020-1383(09)00642-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Kawabata, M. "Signal transduction by bone morphogenetic proteins." Cytokine & Growth Factor Reviews 9, no. 1 (March 1, 1998): 49–61. http://dx.doi.org/10.1016/s1359-6101(97)00036-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Vukičević, Slobodan, Lovorka Grgurević, and Marko Pećina. "Clinical need for bone morphogenetic proteins." International Orthopaedics 41, no. 11 (June 29, 2017): 2415–16. http://dx.doi.org/10.1007/s00264-017-3550-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Bone morphogenetic proteins' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography